These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1525351

  • 1. Sensitization primes platelet-activating factor (PAF)-induced accumulation of eosinophils in mouse skin lesions: contribution of cytokines to the response.
    Yukawa T, Terashi K, Terashi Y, Arima M, Sagara H, Motojima S, Fukuda T, Makino S.
    J Lipid Mediat; 1992; 5(2):121-6. PubMed ID: 1525351
    [Abstract] [Full Text] [Related]

  • 2. Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils.
    van der Bruggen T, Kanters D, Tool AT, Raaijmakers JA, Lammers JW, Verhoeven AJ, Koenderman L.
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):103-9. PubMed ID: 9449508
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T, de Weck AL, Dahinden CA.
    J Immunol; 1991 Jul 01; 147(1):237-42. PubMed ID: 1711077
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.
    Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651
    [Abstract] [Full Text] [Related]

  • 5. The role of basophils in allergic disease.
    Knol EF, Mul FP, Lie WJ, Verhoeven AJ, Roos D.
    Eur Respir J Suppl; 1996 Aug 15; 22():126s-131s. PubMed ID: 8871057
    [Abstract] [Full Text] [Related]

  • 6. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K, MacGlashan DW, Lichtenstein LM, Bochner BS, Schleimer RP.
    J Immunol; 1993 Nov 01; 151(9):4989-97. PubMed ID: 8409452
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
    Ebisawa M, Liu MC, Yamada T, Kato M, Lichtenstein LM, Bochner BS, Schleimer RP.
    J Immunol; 1994 May 01; 152(9):4590-6. PubMed ID: 8157972
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor prime actin-polymerization in human eosinophils: a study with hypodense and normodense eosinophils from patients with atopic dermatitis.
    Kaatz M, Berod L, Czech W, Idzko M, Lagadari M, Bauer A, Norgauer J.
    Int J Mol Med; 2004 Dec 01; 14(6):1055-60. PubMed ID: 15547673
    [Abstract] [Full Text] [Related]

  • 9. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
    Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB.
    Immunology; 1990 Oct 01; 71(2):258-65. PubMed ID: 2228026
    [Abstract] [Full Text] [Related]

  • 10. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
    Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM.
    Am J Respir Cell Mol Biol; 1997 Apr 01; 16(4):455-63. PubMed ID: 9115757
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
    Wallen N, Kita H, Weiler D, Gleich GJ.
    J Immunol; 1991 Nov 15; 147(10):3490-5. PubMed ID: 1940348
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-2 activates human peripheral blood eosinophils.
    Hoenstein R, Admon D, Solomon A, Norris A, Moqbel R, Levi-Schaffer F.
    Cell Immunol; 2001 Jun 15; 210(2):116-24. PubMed ID: 11520078
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor.
    Kishimoto S, Shimazu W, Izumi T, Shimizu T, Fukuda T, Makino S, Sugiura T, Waku K.
    Int Arch Allergy Immunol; 1996 Jun 15; 111 Suppl 1():63-5. PubMed ID: 8906117
    [Abstract] [Full Text] [Related]

  • 14. The role of lipocortin-1 in the inhibitory action of dexamethasone on eosinophil trafficking in cutaneous inflammatory reactions in the mouse.
    Teixeira MM, Das AM, Miotla JM, Perretti M, Hellewell PG.
    Br J Pharmacol; 1998 Feb 15; 123(3):538-44. PubMed ID: 9504395
    [Abstract] [Full Text] [Related]

  • 15. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
    Horie S, Kita H.
    J Immunol; 1994 Jun 01; 152(11):5457-67. PubMed ID: 7514638
    [Abstract] [Full Text] [Related]

  • 16. Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils.
    Wang P, Wu P, Cheewatrakoolpong B, Myers JG, Egan RW, Billah MM.
    J Immunol; 1998 May 01; 160(9):4427-32. PubMed ID: 9574547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx.
    Vieira-de-Abreu A, Amendoeira FC, Gomes GS, Zanon C, Chedier LM, Figueiredo MR, Kaplan MA, Frutuoso VS, Castro-Faria-Neto HC, Weller PF, Bandeira-Melo C, Bozza PT.
    Int Immunopharmacol; 2005 Dec 01; 5(13-14):1966-74. PubMed ID: 16275631
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.